2029-10 AHRQ Health Services Research Projects

April 19, 2024 0

Due: October 6, 2029 The purpose of this Notice of Funding Opportunity (NOFO) is to seek health services research grant applications focused on AHRQ research priorities, including improving healthcare quality and patient safety, improving healthcare Read More

2024-07 Developmental Sciences Funding Opportunity

April 19, 2024 0

Due: July 30, 2024 Developmental Sciences supports basic research that increases our understanding of perceptual, cognitive, linguistic, social, cultural, and biological processes related to human development across the lifespan. Research supported by this program will Read More

Vaccines Capability Area

April 19, 2024 0

Anticipated Release Date: Q3FY24 OR Q4FY24 Multiple Topics TBD—Possible 3 or 4 The goal of the Vaccines Capability Area is to conduct research in order to develop lead candidate vaccines and pretreatments that can be administered Read More

Microphysiological Systems To Expand Diagnostic Capabilities

April 19, 2024 0

Anticipated Release Date: Q2FY24 Develop a microphysiological system that realistically mimics human physiological responses to threat exposures for rapid discovery of diagnostic biomarkers. Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium Read More

Consolidated Nerve Agent Treatment System

April 19, 2024 0

Anticipated Release Date: Q1FY25 FDA approval of a multi-drug autoinjector to reduce logistical burden on the warfighter and increase survivability Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous solicitations Read More

Small Molecule Therapeutics

April 19, 2024 0

Anticipated Release Date: Q1FY24 OR Q2FY24 Small Molecule Therapeutics Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end Read More

1 2 3 4 8